Suppr超能文献

异波帕胺对周围血流动力学的影响。

Effect of ibopamine on peripheral haemodynamics.

作者信息

Longhini C, Musacci G F, Ansani L, Toselli T, Artioli M, Bianco L, Ghirardi P

出版信息

Eur J Clin Pharmacol. 1983;24(5):585-9. doi: 10.1007/BF00542205.

Abstract

Peripheral haemodynamics was studied in healthy volunteers by strain gauge plethysmography after administration of ibopamine (IB), diisobutyric ester of N-methyl-dopamine, an orally active dopaminergic agonist. Seven subjects received a single oral dose of ibopamine of 150 mg and 6 received a daily dose of 150 mg (50 mg t.i.d.) for 5 consecutive days. Arterial resting blood flow and venous capacity increased and peripheral resistance decreased significantly. Six further subjects were then studied; 3 h after an oral dose of ibopamine 150 mg, the parenteral administration of Sulpiride 50 mg, a specific vascular dopaminergic antagonist, was found significantly to counteract its peripheral activity. Heart rate and arterial blood pressure were never affected and tolerability was good.

摘要

通过应变计体积描记法对健康志愿者服用异波帕明(IB)(N-甲基多巴胺的二异丁酸酯,一种口服活性多巴胺能激动剂)后的外周血流动力学进行了研究。7名受试者单次口服150毫克异波帕明,6名受试者连续5天每日服用150毫克(50毫克,每日三次)。静息动脉血流量和静脉容量增加,外周阻力显著降低。然后对另外6名受试者进行了研究;口服150毫克异波帕明3小时后,发现胃肠外给予50毫克舒必利(一种特异性血管多巴胺能拮抗剂)可显著抵消其外周活性。心率和动脉血压从未受到影响,耐受性良好。

相似文献

1
Effect of ibopamine on peripheral haemodynamics.
Eur J Clin Pharmacol. 1983;24(5):585-9. doi: 10.1007/BF00542205.

引用本文的文献

2
Haemodynamic evaluation of ibopamine in severe congestive heart failure.
Eur J Clin Pharmacol. 1984;26(1):19-22. doi: 10.1007/BF00546702.
3
Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure.
Br J Clin Pharmacol. 1985 May;19(5):613-8. doi: 10.1111/j.1365-2125.1985.tb02688.x.
4
Inhibition of prolactin and aldosterone secretion by the dopamine derivative ibopamine.
Eur J Clin Pharmacol. 1986;29(5):629-30. doi: 10.1007/BF00635905.
5
Early cardiovascular changes with ibopamine: evidence for a biphasic haemodynamic action.
Br J Clin Pharmacol. 1987 Oct;24(4):435-42. doi: 10.1111/j.1365-2125.1987.tb03195.x.

本文引用的文献

4
Ibopamine (SB 7505) in normal subjects and in chronic renal failure: a preliminary report.
Br J Clin Pharmacol. 1981 Jan;11(1):69-72. doi: 10.1111/j.1365-2125.1981.tb01104.x.
5
Effectiveness of ibopamine in the management of ascitic liver cirrhosis--a controlled study v placebo and frusemide.
Br J Clin Pharmacol. 1981 Dec;12(6):813-8. doi: 10.1111/j.1365-2125.1981.tb01312.x.
6
Renal effect of SB 7505: a double-blind study.
Eur J Clin Pharmacol. 1981 Feb;19(3):177-80. doi: 10.1007/BF00561945.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验